Incidence of arthralgia syndrome (AS) related to aromatase inhibitors (AIs) in postmenopausal women with early breast cancer (EBC)

被引：0
|
作者：
Maisano, R. [1 ]
Maisano, R. [1 ]
Azzarello, D. [1 ]
Del Medico, P. [1 ]
Giannicola, R. [1 ]
Giuffre, C. [1 ]
Panuccio, V. [1 ]
Raffaele, M. [1 ]
Zavettieri, M. [1 ]
Falzea, A. [1 ]
Nardi, M. [1 ]
机构：
[1] Oncol Med, Reggio Di Calabria, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11603
引用
收藏
页码：CP42 / U381
页数：2
相关论文
共 50 条
  • [41] In postmenopausal women with breast cancer treated with aromatase inhibitors, denosumab reduced fractures
    Wilcken, Nicholas
    Lee, Clara Inkyung
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 163 (06)
  • [42] Treatment with aromatase inhibitors for breast cancer is associated with bone loss in postmenopausal women
    不详
    [J]. Drugs & Therapy Perspectives, 2009, 25 (10) : 23 - 26
  • [43] The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer
    Benson, JR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6807 - 6809
  • [44] An economic analysis of arthralgia/myalgia versus recurrence in women with hormone receptor-positive (HR plus ) breast cancer (BC) on aromatase inhibitors (AIs)
    Hadji, P.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 210 - 211
  • [45] Exemestane versus anastrozole in postmenopausal women with hormone positive early breast cancer (EBC)
    Abdel-Halim, I.
    El-Sadda, W.
    El-Sherbeiny, E.
    El-Ebrashy, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S49 - S49
  • [46] Clinical Utility of Aromatase Inhibitors as Adjuvant Treatment in Postmenopausal Early Breast Cancer
    Loaiza-Bonilla, Arturo
    Socola, Francisco
    Glueck, Stefan
    [J]. CLINICAL MEDICINE INSIGHTS-WOMENS HEALTH, 2013, 6 : 1 - 11
  • [47] Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer
    Kudchadkar, R
    O'Regan, RM
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (03) : 145 - 163
  • [48] PHARMACOGENETICS OF AROMATASE INHIBITORS (AIS) IN PATIENTS WITH METASTATIC BREAST CANCER
    Ferraldeschi, R.
    Arnedos, M.
    Hadfield, K.
    Ahern, R.
    Drury, S.
    Roberts, S.
    Howell, A.
    Smith, I.
    Newman, W.
    Dowsett, M.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 60 - 60
  • [49] Prevalence of arthralgia and myalgia in patients with breast cancer treated with aromatase inhibitors
    Tellez Bernal, Eduardo
    Falcon Flores, Oscar
    Mendez Tamariz, Rosa Maria
    Zalapa Velazquez, Rita
    Aguilar Priego, Jose Manuel
    Mendoza Lopez, Alma
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2016, 15 (03): : 116 - 120
  • [50] Aromatase inhibitors: A new reality for the adjuvant endocrine treatment of early-stage breast cancer in postmenopausal women
    Colozza, M.
    Califano, R.
    Minenza, E.
    Dinh, P.
    Azambuja, E.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (06) : 564 - 574
12345